(Q36616002)
Statements
1 reference
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial (English)
1 reference
S Lorenzen
1 reference
J Duyster
1 reference
C Lersch
1 reference
S von Delius
1 reference
M Hennig
1 reference
R Bredenkamp
1 reference
C Peschel
1 reference
F Lordick
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference